<DOC>
	<DOCNO>NCT00047125</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Giving radiation therapy different way may kill tumor cell . It yet know regimen radiation therapy effective treating patient metastases lymph node neck . PURPOSE : Randomized phase III trial compare different radiation therapy regimens treat patient metastasis lymph node neck unknown primary tumor .</brief_summary>
	<brief_title>Radiation Therapy Treating Patients With Metastases Lymph Nodes Neck From Unknown Primary Tumor</brief_title>
	<detailed_description>OBJECTIVES : - Compare disease-free survival patient cervical lymph node metastases squamous cell carcinoma unknown primary treat selective irradiation v extensive irradiation . - Compare overall survival patient treat regimen . - Compare incidence acute late side effect head neck region patient treat regimen . - Compare control neck incidence subsequent primary head neck region patient treat regimen . - Compare quality life patient treat regimen . OUTLINE : This randomize , open-label , multicenter study . Patients stratify accord disease stage ( N1-2a v N2b-3 ) , radiation technique ( 2D vs 3D conformal vs intensity-modulated ) , participate center . Patients randomize 1 2 treatment arm . - Arm I : Patients undergo selective irradiation ipsilateral level neck daily 5 day week 6 week . - Arm II : Patients undergo extensive irradiation neck ( nasopharyngeal , oropharyngeal , hypopharyngeal , laryngeal mucosa ipsilateral neck node area side neck ) daily 5 day week 6 week . In arm , treatment continue absence unacceptable toxicity disease progression . Quality life assess baseline , week 4 , last day therapy , every 3 month 1 year . Patients follow day 30 , every 3 month 3 year , every 6 month 2 year , annually thereafter . PROJECTED ACCRUAL : A total 600 patient ( 300 per treatment arm ) accrue study within 7 year .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Neoplasms , Unknown Primary</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm squamous cell carcinoma cervical lymph node metastasis unknown primary tumor Histopathological grade WHO 13 Pathological stage N1 , N2a , N2b , N3 No N2c ( i.e. , bilateral metastatic node ) No single node supraclavicular fossa submandibular area No evidence primary tumor head neck , lung , esophageal , site Prior radical , radical modify , extend radical dissection within past 8 week Selective neck dissection allow ( surgeon must justify standard procedure perform ) No node excision alone R0 R1 disease dissection No distant metastases PATIENT CHARACTERISTICS : Age 18 Performance status ECOG 02 OR Karnofsky 60100 % Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other Able willing complete quality life questionnaires No prior concurrent malignancy except adequately treat basal cell skin cancer carcinoma situ cervix No psychological , familial , sociological , geographical condition would preclude study compliance Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Concurrent chemotherapy allow Endocrine therapy Not specify Radiotherapy Not specify Surgery See Disease Characteristics Other No prior therapy carcinoma unknown primary except neck dissection</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>newly diagnose carcinoma unknown primary</keyword>
	<keyword>squamous cell carcinoma unknown primary</keyword>
</DOC>